Thank you, Mr. Chair, and hello to my colleagues.
I want to thank the witnesses for joining us today.
As the chair just mentioned, I am vice-chair of the Standing Committee on Public Accounts, so if there's one thing I can do for this committee, despite not having attended the previous meetings, it's add some perspective.
At the Standing Committee on Public Accounts, I introduced a motion that was adopted unanimously, calling on the government to produce, by a certain deadline, the unredacted contracts with pharmaceutical companies from which it had purchased COVID‑19 vaccines. Before the deadline, we received all the contracts signed with the six pharmaceutical companies from Public Services and Procurement Canada, and those contracts were unredacted.
Why was the Standing Committee on Public Accounts able to adopt this motion and get Public Services and Procurement Canada to comply with our request for such sensitive contracts, when a similar motion moved at this committee didn't meet with the same response, the same level of satisfaction or, most importantly, the same success rate? When I look at the documents that were produced and I see how much was redacted by the government, whereas McKinsey sent in unredacted documents, I can't help but ask myself some questions. Is it due to bad faith or incompetence? I would rather it was the first and that it could be fixed so that this committee could finally get access to the documents it requested. The law clerk just reiterated that this committee has the right to make such requests.
I'm going to start with you, Mr. Shea. At the last meeting, I gather that you said the documents had been sent over redacted, in accordance with the instructions Mr. Harper had given when he was in office.
Is that right, Mr. Shea?